You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
|No Recent Quote currently available|
My Portfolio Tracker
One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.
Dec 12, 2012 (Fast Lane via COMTEX) -- Below are the three companies in the Health Care Technology industry with the lowest price to earnings to growth (PEG) ratios. PEG is valuable in assessing the tradeoff between the price of a stock and expected growth. Generally, the lower the PEG, the better.
MedAssets (NASDAQ:MDAS) is lowest with a PEG ratio of 0.92. MedAssets Inc. provides technology-enabled products and services for hospitals and health systems. The Company's technology-enabled solutions are delivered primarily through company-hosted, or ASP-based, software supported by enterprise-wide sales, account management, implementation services and consulting. MedAssets has traded 50,000 shares thus far today, vs. average volume of 417,000 shares per day. The stock has underperformed the Dow (-0.8% to the Dow's 0.1%) and underperformed the S&P 500 (-0.8% to the S&P's 0.2%) during today's trading.
Following is Omnicell (NASDAQ:OMCL) with a PEG ratio of 1.03. Finishing up the bottom three is Allscripts Healthcare Solutions (NASDAQ:MDRX), with a PEG ratio of 1.03. ---------------------------------------------------------------------------------------------
Financial News Network Online (FNNO) is a leading provider of digital financial news content for distribution on the web. You can count on FNNO to bring you the latest market news, earnings reports, analyst comments, economic data reports and more. Visit http://www.fnno.com today.
Copyright, Comtex News Network, Inc. 2012
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Copyright 2014 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.